Profile data is unavailable for this security.
About the company
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
- Revenue in USD (TTM)0.00
- Net income in USD-444.28m
- Incorporated2000
- Employees376.00
- LocationMadrigal Pharmaceuticals Inc200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN 19428-2978United StatesUSA
- Phone+1 (404) 380-9263
- Fax+1 (302) 655-5049
- Websitehttps://www.madrigalpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Insmed Inc | 315.49m | -746.89m | 3.68bn | 912.00 | -- | -- | -- | 11.67 | -5.23 | -5.23 | 2.20 | -3.13 | 0.2357 | 0.8971 | 9.32 | 345,936.40 | -55.80 | -40.96 | -72.23 | -46.88 | 78.07 | 77.99 | -236.74 | -212.92 | 1.61 | -16.08 | 1.64 | -- | 24.39 | 98.78 | -55.66 | -- | -2.15 | -- |
Simply Good Foods Co | 1.27bn | 140.76m | 3.75bn | 271.00 | 26.95 | 2.28 | 23.18 | 2.96 | 1.39 | 1.39 | 12.53 | 16.48 | 0.5977 | 6.91 | 8.56 | 4,671,908.00 | 6.65 | 3.66 | 6.95 | 3.83 | 37.26 | 38.90 | 11.12 | 6.80 | 3.09 | 9.26 | 0.1261 | 0.00 | 6.33 | 23.56 | 23.03 | 13.65 | 47.09 | -- |
Crinetics Pharmaceuticals Inc | 1.97m | -235.46m | 4.05bn | 290.00 | -- | 4.61 | -- | 2,053.38 | -3.77 | -3.77 | 0.0315 | 11.14 | 0.0031 | -- | 0.3653 | 6,806.90 | -35.57 | -42.53 | -37.86 | -45.36 | -- | -- | -11,641.13 | -5,446.39 | -- | -- | 0.00 | -- | -15.28 | 10.57 | -30.88 | -- | 34.65 | -- |
Alkermes Plc | 1.73bn | 599.95m | 4.09bn | 2.10k | 6.90 | 3.26 | 6.15 | 2.37 | 3.50 | 2.53 | 10.05 | 7.42 | 0.8532 | 1.32 | 5.81 | 821,991.40 | 29.65 | 1.34 | 38.77 | 1.74 | 85.31 | 83.32 | 34.76 | 2.12 | 2.77 | -- | 0.1878 | 0.00 | 49.61 | 8.74 | 1,665.99 | -- | -7.10 | -- |
Alpine Immune Sciences Inc | 56.52m | -36.84m | 4.46bn | 142.00 | -- | 12.80 | -- | 78.85 | -0.6837 | -0.6837 | 1.04 | 5.08 | 0.1778 | -- | 159.21 | 398,035.20 | -11.59 | -21.93 | -13.48 | -27.81 | -- | -- | -65.17 | -170.16 | -- | -- | 0.00 | -- | 95.84 | 142.30 | 44.28 | -- | -0.3253 | -- |
Immunovant Inc | 0.00 | -243.45m | 4.46bn | 164.00 | -- | 6.56 | -- | -- | -1.83 | -1.83 | 0.00 | 4.68 | 0.00 | -- | -- | 0.00 | -41.70 | -- | -44.49 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -34.60 | -- | -- | -- |
Nuvalent Inc | 0.00 | -145.51m | 4.58bn | 106.00 | -- | 6.77 | -- | -- | -2.41 | -2.41 | 0.00 | 10.47 | 0.00 | -- | -- | 0.00 | -24.88 | -- | -26.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -54.20 | -- | -- | -- |
Krystal Biotech Inc | 95.95m | 57.16m | 4.69bn | 229.00 | 87.19 | 5.86 | 73.89 | 48.84 | 1.88 | 1.88 | 3.38 | 28.02 | 0.1385 | -- | -- | 418,991.30 | 8.25 | -11.50 | 8.78 | -12.01 | 94.25 | -- | 59.57 | -492.85 | 12.42 | -- | 0.00 | -- | -- | -- | 107.81 | -- | 39.49 | -- |
Madrigal Pharmaceuticals Inc | 0.00 | -444.28m | 4.69bn | 376.00 | -- | 5.35 | -- | -- | -23.08 | -23.08 | 0.00 | 41.13 | 0.00 | -- | -- | 0.00 | -62.81 | -62.09 | -73.92 | -74.81 | -- | -- | -- | -- | 9.39 | -- | 0.1201 | -- | -- | -- | -26.50 | -- | 132.01 | -- |
Apellis Pharmaceuticals Inc | 524.07m | -417.27m | 5.01bn | 702.00 | -- | 18.79 | -- | 9.57 | -3.46 | -3.46 | 4.33 | 2.20 | 0.5788 | 0.5747 | 3.50 | 746,538.40 | -46.09 | -73.88 | -57.28 | -90.03 | 86.47 | -- | -79.62 | -326.49 | 3.02 | -39.71 | 0.6087 | -- | 425.83 | -- | 18.94 | -- | -- | -- |
Immunitybio Inc | 302.00k | -600.96m | 5.29bn | 628.00 | -- | -- | -- | 17,518.20 | -1.05 | -1.05 | 0.0005 | -1.02 | 0.0008 | -- | 0.1677 | 480.89 | -161.65 | -112.76 | -946.50 | -316.07 | -- | -- | -199,138.70 | -37,700.74 | -- | -1.92 | 5.32 | -- | 159.17 | 67.62 | -40.00 | -- | 18.48 | -- |
Ionis Pharmaceuticals Inc | 776.62m | -384.77m | 5.45bn | 927.00 | -- | 18.35 | -- | 7.01 | -2.67 | -2.67 | 5.40 | 2.03 | 0.275 | 0.379 | 81.52 | 837,777.80 | -13.62 | -6.30 | -15.20 | -7.44 | 98.72 | 98.75 | -49.54 | -21.23 | 7.28 | -- | 0.8114 | -- | 34.10 | 5.60 | -35.80 | -- | 11.83 | -- |
Organon & Co | 6.35bn | 1.05bn | 5.61bn | 10.00k | 5.35 | 116.20 | 4.34 | 0.8833 | 4.08 | 4.08 | 24.71 | 0.1876 | 0.5603 | 2.18 | 4.24 | 634,700.00 | 9.24 | 16.53 | 11.79 | 20.97 | 59.04 | 65.12 | 16.50 | 26.79 | 1.15 | 2.36 | 0.9945 | 8.25 | 1.44 | -8.52 | 11.56 | -13.83 | 20.72 | -- |
BridgeBio Pharma Inc | 218.60m | -538.26m | 5.63bn | 550.00 | -- | -- | -- | 25.76 | -3.23 | -3.23 | 1.29 | -5.61 | 0.2964 | -- | -- | 397,449.10 | -74.13 | -72.44 | -90.19 | -89.72 | 98.91 | 94.41 | -250.09 | -1,225.66 | -- | -11.48 | 2.53 | -- | -88.02 | -- | -33.67 | -- | -40.94 | -- |
Halozyme Therapeutics, Inc. | 862.99m | 318.80m | 5.69bn | 373.00 | 18.49 | 31.98 | 14.19 | 6.59 | 2.42 | 2.42 | 6.54 | 1.40 | 0.4874 | 1.34 | 4.42 | 2,313,644.00 | 18.01 | 18.22 | 19.22 | 21.97 | 78.50 | 79.05 | 36.94 | 39.36 | 5.36 | 966.62 | 0.8941 | 0.00 | 25.62 | 40.43 | 39.31 | -- | 26.82 | -- |
Data as of May 17 2024. Currency figures normalised to Madrigal Pharmaceuticals Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Janus Henderson Investors US LLCas of 31 Dec 2023 | 2.88m | 14.48% |
Baker Bros. Advisors LPas of 21 Mar 2024 | 1.97m | 9.90% |
Avoro Capital Advisor LLCas of 31 Dec 2023 | 1.89m | 9.49% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.63m | 8.18% |
Paulson & Co., Inc.as of 31 Dec 2023 | 1.11m | 5.56% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.08m | 5.44% |
RTW Investments LPas of 31 Dec 2023 | 815.19k | 4.10% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 700.74k | 3.52% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 556.32k | 2.80% |
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 377.83k | 1.90% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.